Rallybio (RLYB) Tax Rate (2020 - 2026)
Rallybio (RLYB) posted Tax Rate of 0.01% for Q4 2020.
Rallybio (RLYB) Tax Rate (2020 - 2026) Analysis & Trends
Rallybio has reported Tax Rate for 1 years, with the latest figure at 0.01% in Q4 2020.
- Quarterly Tax Rate changed N/A year-over-year to 0.01% in Q4 2020, while the trailing twelve-month figure through Dec 2021 was 0.0% (changed N/A YoY) and the FY2020 annual result came in at 0.06%, changed N/A from the prior year.
- Tax Rate steadied at 0.01% in Q4 2020 per RLYB's latest filing.
- Over five years, Tax Rate peaked at 0.01% in Q4 2020 and troughed at 0.01% in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.91% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 24.15% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 7.49% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 34.12% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -16.71% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Rallybio | 94.61 Mn | 94.61 Mn | - | 2.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.94% |
| Jun 30, 2026 | 2.94% |
| Jun 30, 2026 | 2.94% |
| Dec 31, 2020 | -0.01% |
| Dec 31, 2020 | -0.01% |
| Dec 31, 2020 | -0.01% |